{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:47:08Z","timestamp":1790714828244,"version":"4.1.0"},"reference-count":87,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS080833"],"award-info":[{"award-number":["R01NS080833"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI132387"],"award-info":[{"award-number":["R01AI132387"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI139087"],"award-info":[{"award-number":["R01AI139087"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS106159"],"award-info":[{"award-number":["R21NS106159"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosbiology.org"],"crossmark-restriction":false},"short-container-title":["PLoS Biol"],"DOI":"10.1371\/journal.pbio.3000618","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T17:36:44Z","timestamp":1584466604000},"page":"e3000618","update-policy":"https:\/\/doi.org\/10.1371\/journal.pbio.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9884-8194","authenticated-orcid":true,"given":"Linxiang","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9527-2310","authenticated-orcid":true,"given":"Geoffrey","family":"Masuyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Ichiro","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Burgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2870-7641","authenticated-orcid":true,"given":"Laura","family":"Lovelock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Fen","family":"Coker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-min","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4777-3417","authenticated-orcid":true,"given":"P\u00e5l","family":"Stenmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1744-7293","authenticated-orcid":true,"given":"Min","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"issue":"Pt A","key":"pbio.3000618.ref001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.toxicon.2015.09.011","article-title":"Genetic diversity within the botulinum neurotoxin-producing bacteria and their neurotoxins","volume":"107","author":"KK Hill","year":"2015","journal-title":"Toxicon"},{"issue":"8","key":"pbio.3000618.ref002","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrmicro3295","article-title":"Botulinum neurotoxins: genetic, structural and mechanistic insights","volume":"12","author":"O Rossetto","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"pbio.3000618.ref003","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1146\/annurev-biochem-013118-111654","article-title":"Botulinum and Tetanus Neurotoxins","volume":"88","author":"M Dong","year":"2019","journal-title":"Annual review of biochemistry"},{"issue":"8","key":"pbio.3000618.ref004","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"SS Arnon","year":"2001","journal-title":"Jama"},{"issue":"2","key":"pbio.3000618.ref005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"G Schiavo","year":"2000","journal-title":"Physiological reviews"},{"key":"pbio.3000618.ref006","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.biochem.051908.125345","article-title":"Botulinum neurotoxin: a marvel of protein design","volume":"79","author":"M. Montal","year":"2010","journal-title":"Annual review of biochemistry"},{"issue":"1","key":"pbio.3000618.ref007","article-title":"Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature","volume":"9","author":"MW Peck","year":"2017","journal-title":"Toxins (Basel)"},{"issue":"Pt 13","key":"pbio.3000618.ref008","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1242\/jcs.103564","article-title":"Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins","volume":"125","author":"L Peng","year":"2012","journal-title":"J Cell Sci"},{"issue":"2","key":"pbio.3000618.ref009","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0167-4781(96)00006-1","article-title":"Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms","volume":"1307","author":"K Moriishi","year":"1996","journal-title":"Biochim Biophys Acta"},{"issue":"37","key":"pbio.3000618.ref010","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.1021\/bi100865f","article-title":"Identification of a Unique Ganglioside Binding Loop within Botulinum Neurotoxins C and D-SA","volume":"49","author":"AP Karalewitz","year":"2010","journal-title":"Biochemistry"},{"issue":"2","key":"pbio.3000618.ref011","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/jit449","article-title":"A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins","volume":"209","author":"JR Barash","year":"2014","journal-title":"J Infect Dis"},{"issue":"2","key":"pbio.3000618.ref012","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/infdis\/jit450","article-title":"Molecular characterization of a novel botulinum neurotoxin type H gene","volume":"209","author":"N Dover","year":"2014","journal-title":"J Infect Dis"},{"issue":"3","key":"pbio.3000618.ref013","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/infdis\/jiv327","article-title":"A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin","volume":"213","author":"SE Maslanka","year":"2016","journal-title":"J Infect Dis"},{"key":"pbio.3000618.ref014","doi-asserted-by":"crossref","first-page":"14130","DOI":"10.1038\/ncomms14130","article-title":"Identification and characterization of a novel botulinum neurotoxin","volume":"8","author":"S Zhang","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"pbio.3000618.ref015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.chom.2017.12.018","article-title":"Identification of a Botulinum Neurotoxin-like Toxin in a Commensal Strain of Enterococcus faecium","volume":"23","author":"S Zhang","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"1","key":"pbio.3000618.ref016","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1038\/s41467-019-10732-w","article-title":"A neurotoxin that specifically targets Anopheles mosquitoes","volume":"10","author":"E Contreras","year":"2019","journal-title":"Nat Commun"},{"issue":"9","key":"pbio.3000618.ref017","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrm2002","article-title":"SNAREs\u2014engines for membrane fusion","volume":"7","author":"R Jahn","year":"2006","journal-title":"Nature reviews"},{"issue":"5913","key":"pbio.3000618.ref018","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1126\/science.1161748","article-title":"Membrane fusion: grappling with SNARE and SM proteins","volume":"323","author":"TC Sudhof","year":"2009","journal-title":"Science"},{"issue":"8","key":"pbio.3000618.ref019","first-page":"314","article-title":"How do tetanus and botulinum toxins bind to neuronal membranes?","volume":"11","author":"C. Montecucco","year":"1986","journal-title":"TIBS"},{"issue":"Pt A","key":"pbio.3000618.ref020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.toxicon.2015.09.009","article-title":"The long journey of botulinum neurotoxins into the synapse","volume":"107","author":"A. Rummel","year":"2015","journal-title":"Toxicon"},{"issue":"3","key":"pbio.3000618.ref021","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-2836(02)01403-1","article-title":"Two carbohydrate binding sites in the H(CC)-domain of tetanus neurotoxin are required for toxicity","volume":"326","author":"A Rummel","year":"2003","journal-title":"Journal of molecular biology"},{"issue":"3","key":"pbio.3000618.ref022","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2958.2003.03872.x","article-title":"The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction","volume":"51","author":"A Rummel","year":"2004","journal-title":"Molecular microbiology"},{"issue":"34","key":"pbio.3000618.ref023","doi-asserted-by":"crossref","first-page":"32274","DOI":"10.1074\/jbc.M103285200","article-title":"The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin","volume":"276","author":"C Fotinou","year":"2001","journal-title":"The Journal of biological chemistry"},{"issue":"8","key":"pbio.3000618.ref024","doi-asserted-by":"crossref","first-page":"e1000129","DOI":"10.1371\/journal.ppat.1000129","article-title":"Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction","volume":"4","author":"P Stenmark","year":"2008","journal-title":"PLoS Pathog"},{"key":"pbio.3000618.ref025","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/ncomms3058","article-title":"Structure of dual receptor binding to botulinum neurotoxin B","volume":"4","author":"RP Berntsson","year":"2013","journal-title":"Nat Commun"},{"issue":"39","key":"pbio.3000618.ref026","doi-asserted-by":"crossref","first-page":"34015","DOI":"10.1074\/jbc.M111.272054","article-title":"Unique ganglioside recognition strategies for clostridial neurotoxins","volume":"286","author":"MA Benson","year":"2011","journal-title":"The Journal of biological chemistry"},{"issue":"8","key":"pbio.3000618.ref027","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.15252\/embr.201744198","article-title":"The structure of the tetanus toxin reveals pH-mediated domain dynamics","volume":"18","author":"G Masuyer","year":"2017","journal-title":"EMBO Rep"},{"issue":"1","key":"pbio.3000618.ref028","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/jacs.6b09534","article-title":"Glycans Confer Specificity to the Recognition of Ganglioside Receptors by Botulinum Neurotoxin A","volume":"139","author":"C Hamark","year":"2017","journal-title":"J Am Chem Soc"},{"issue":"1","key":"pbio.3000618.ref029","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41467-017-01534-z","article-title":"Structural basis for the unique ganglioside and cell membrane recognition mechanism of botulinum neurotoxin DC","volume":"8","author":"S Zhang","year":"2017","journal-title":"Nat Commun"},{"issue":"14","key":"pbio.3000618.ref030","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1016\/S0021-9258(17)34087-5","article-title":"Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes","volume":"269","author":"T Nishiki","year":"1994","journal-title":"The Journal of biological chemistry"},{"issue":"3","key":"pbio.3000618.ref031","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0014-5793(95)01471-3","article-title":"The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b\/GD1a","volume":"378","author":"T Nishiki","year":"1996","journal-title":"FEBS Lett"},{"issue":"7","key":"pbio.3000618.ref032","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1083\/jcb.200305098","article-title":"Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells","volume":"162","author":"M Dong","year":"2003","journal-title":"The Journal of cell biology"},{"issue":"29","key":"pbio.3000618.ref033","doi-asserted-by":"crossref","first-page":"30865","DOI":"10.1074\/jbc.M403945200","article-title":"Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G","volume":"279","author":"A Rummel","year":"2004","journal-title":"The Journal of biological chemistry"},{"issue":"7","key":"pbio.3000618.ref034","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1083\/jcb.200707184","article-title":"Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons","volume":"179","author":"M Dong","year":"2007","journal-title":"The Journal of cell biology"},{"issue":"5773","key":"pbio.3000618.ref035","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"M Dong","year":"2006","journal-title":"Science"},{"issue":"8","key":"pbio.3000618.ref036","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.febslet.2006.02.074","article-title":"The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves","volume":"580","author":"S Mahrhold","year":"2006","journal-title":"FEBS Lett"},{"issue":"1","key":"pbio.3000618.ref037","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/BJ20130391","article-title":"Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type","volume":"453","author":"S Mahrhold","year":"2013","journal-title":"E. The Biochemical journal"},{"issue":"12","key":"pbio.3000618.ref038","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1091\/mbc.e08-07-0765","article-title":"Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons","volume":"19","author":"M Dong","year":"2008","journal-title":"Molecular biology of the cell"},{"issue":"3","key":"pbio.3000618.ref039","doi-asserted-by":"crossref","first-page":"e1002008","DOI":"10.1371\/journal.ppat.1002008","article-title":"Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors","volume":"7","author":"L Peng","year":"2011","journal-title":"PLoS Pathog"},{"issue":"7","key":"pbio.3000618.ref040","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nsmb.3245","article-title":"N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A","volume":"23","author":"G Yao","year":"2016","journal-title":"Nature structural & molecular biology"},{"issue":"17","key":"pbio.3000618.ref041","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1042\/BCJ20160439","article-title":"Only the complex N559-glycan in the synaptic vesicle glycoprotein 2C mediates high affinity binding to botulinum neurotoxin serotype A1","volume":"473","author":"S Mahrhold","year":"2016","journal-title":"The Biochemical journal"},{"issue":"7481","key":"pbio.3000618.ref042","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature12732","article-title":"Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A","volume":"505","author":"RM Benoit","year":"2014","journal-title":"Nature"},{"issue":"6","key":"pbio.3000618.ref043","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1471-4159.2009.06298.x","article-title":"Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor","volume":"110","author":"A Rummel","year":"2009","journal-title":"Journal of neurochemistry"},{"issue":"24","key":"pbio.3000618.ref044","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1021\/bi9002138","article-title":"Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F","volume":"48","author":"Z Fu","year":"2009","journal-title":"Biochemistry"},{"issue":"11","key":"pbio.3000618.ref045","doi-asserted-by":"crossref","first-page":"e1001207","DOI":"10.1371\/journal.ppat.1001207","article-title":"SV2 mediates entry of tetanus neurotoxin into central neurons","volume":"6","author":"FL Yeh","year":"2010","journal-title":"PLoS Pathog"},{"issue":"7122","key":"pbio.3000618.ref046","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nature05411","article-title":"Structural basis of cell surface receptor recognition by botulinum neurotoxin B","volume":"444","author":"Q Chai","year":"2006","journal-title":"Nature"},{"issue":"7122","key":"pbio.3000618.ref047","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/nature05387","article-title":"Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity","volume":"444","author":"R Jin","year":"2006","journal-title":"Nature"},{"issue":"4","key":"pbio.3000618.ref048","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.febslet.2011.12.037","article-title":"Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: increased therapeutic dosage and immunogenicity","volume":"586","author":"J Strotmeier","year":"2012","journal-title":"FEBS Lett"},{"issue":"9","key":"pbio.3000618.ref049","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.str.2013.06.026","article-title":"Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II","volume":"21","author":"RP Berntsson","year":"2013","journal-title":"Structure"},{"issue":"5","key":"pbio.3000618.ref050","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jmb.2010.02.041","article-title":"Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding","volume":"397","author":"P Stenmark","year":"2010","journal-title":"Journal of molecular biology"},{"issue":"22","key":"pbio.3000618.ref051","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1021\/bi4003502","article-title":"Botulinum neurotoxin G binds synaptotagmin-II in a mode similar to that of serotype B: tyrosine 1186 and lysine 1191 cause its lower affinity","volume":"52","author":"G Willjes","year":"2013","journal-title":"Biochemistry"},{"issue":"36","key":"pbio.3000618.ref052","doi-asserted-by":"crossref","first-page":"18098","DOI":"10.1073\/pnas.1908051116","article-title":"Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B","volume":"116","author":"A Flores","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"pbio.3000618.ref053","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.coph.2004.12.006","article-title":"Botulinal neurotoxins: revival of an old killer","volume":"5","author":"C Montecucco","year":"2005","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"pbio.3000618.ref054","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.mib.2012.05.012","article-title":"Clinical applications of botulinum toxin","volume":"15","author":"D. Dressler","year":"2012","journal-title":"Curr Opin Microbiol"},{"issue":"13","key":"pbio.3000618.ref055","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/mds.25582","article-title":"Diffusion, spread, and migration of botulinum toxin","volume":"28","author":"J Ramirez-Castaneda","year":"2013","journal-title":"Mov Disord"},{"issue":"9","key":"pbio.3000618.ref056","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11090491","article-title":"Immunogenicity Associated with Botulinum Toxin Treatment","volume":"491","author":"S Bellows","year":"2019","journal-title":"Toxins (Basel)"},{"issue":"7","key":"pbio.3000618.ref057","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1212\/WNL.53.7.1431","article-title":"Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia","volume":"53","author":"MF Brin","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"pbio.3000618.ref058","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.21724","article-title":"Botulinum toxin type B vs. type A in toxin-naive patients with cervical dystonia: Randomized, double-blind, noninferiority trial","volume":"23","author":"EJ Pappert","year":"2008","journal-title":"Mov Disord"},{"issue":"9","key":"pbio.3000618.ref059","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/01.wnl.0000183055.81056.5c","article-title":"Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia","volume":"65","author":"CL Comella","year":"2005","journal-title":"Neurology"},{"issue":"Pt A","key":"pbio.3000618.ref060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.toxicon.2015.08.001","article-title":"Clinical differences between botulinum neurotoxin type A and B","volume":"107","author":"AR Bentivoglio","year":"2015","journal-title":"Toxicon"},{"key":"pbio.3000618.ref061","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41467-017-00064-y","article-title":"Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors","volume":"8","author":"L Tao","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"pbio.3000618.ref062","doi-asserted-by":"crossref","first-page":"eaau7196","DOI":"10.1126\/sciadv.aau7196","article-title":"Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models","volume":"5","author":"M Elliott","year":"2019","journal-title":"Sci Adv"},{"issue":"6","key":"pbio.3000618.ref063","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2340\/00015555-1606","article-title":"Effect of botulinum toxin concentration on reduction in sweating: a randomized, double-blind study","volume":"93","author":"A Rystedt","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"pbio.3000618.ref064","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1042\/BJ20101042","article-title":"Botulinum neurotoxin serotype D attacks neurons via two carbohydrate binding sites in a ganglioside dependent manner","volume":"431","author":"J Strotmeier","year":"2010","journal-title":"The Biochemical journal"},{"issue":"1","key":"pbio.3000618.ref065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2958.2011.07682.x","article-title":"The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites","volume":"81","author":"J Strotmeier","year":"2011","journal-title":"Molecular microbiology"},{"issue":"48","key":"pbio.3000618.ref066","doi-asserted-by":"crossref","first-page":"40806","DOI":"10.1074\/jbc.M112.404244","article-title":"Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry","volume":"287","author":"AP Karalewitz","year":"2012","journal-title":"The Journal of biological chemistry"},{"issue":"30","key":"pbio.3000618.ref067","doi-asserted-by":"crossref","first-page":"26828","DOI":"10.1074\/jbc.M111.254086","article-title":"Novel Ganglioside-mediated Entry of Botulinum Neurotoxin Serotype D into Neurons","volume":"286","author":"AR Kroken","year":"2011","journal-title":"The Journal of biological chemistry"},{"key":"pbio.3000618.ref068","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1111\/j.1742-4658.2011.08166.x","article-title":"Unique ganglioside binding by botulinum neurotoxins C and D-SA","volume":"278","author":"AR Kroken","year":"2011","journal-title":"The FEBS journal"},{"issue":"2","key":"pbio.3000618.ref069","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbrc.2011.06.173","article-title":"Structural and mutational analyses of the receptor binding domain of botulinum D\/C mosaic neurotoxin: Insight into the ganglioside binding mechanism","volume":"411","author":"N Nuemket","year":"2011","journal-title":"Biochemical and biophysical research communications"},{"issue":"2","key":"pbio.3000618.ref070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1042\/BJ20101042","article-title":"Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner","volume":"431","author":"J Strotmeier","year":"2010","journal-title":"The Biochemical journal"},{"issue":"5","key":"pbio.3000618.ref071","doi-asserted-by":"crossref","first-page":"e1007048","DOI":"10.1371\/journal.ppat.1007048","article-title":"A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency","volume":"14","author":"D Stern","year":"2018","journal-title":"PLoS Pathog"},{"issue":"1","key":"pbio.3000618.ref072","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/jsbi.1998.4007","article-title":"Reconstitution and imaging of a membrane protein in a nanometer-size phospholipid bilayer","volume":"123","author":"TH Bayburt","year":"1998","journal-title":"J Struct Biol"},{"issue":"9","key":"pbio.3000618.ref073","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.febslet.2009.10.024","article-title":"Membrane protein assembly into Nanodiscs","volume":"584","author":"TH Bayburt","year":"2010","journal-title":"FEBS Lett"},{"issue":"4","key":"pbio.3000618.ref074","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cell.2006.10.030","article-title":"Molecular anatomy of a trafficking organelle","volume":"127","author":"S Takamori","year":"2006","journal-title":"Cell"},{"issue":"9","key":"pbio.3000618.ref075","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0968-0004(00)01626-1","article-title":"How proteins adapt to a membrane-water interface","volume":"25","author":"JA Killian","year":"2000","journal-title":"Trends Biochem Sci"},{"issue":"12","key":"pbio.3000618.ref076","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0041-0101(01)00101-5","article-title":"A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice","volume":"39","author":"KR Aoki","year":"2001","journal-title":"Toxicon"},{"key":"pbio.3000618.ref077","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.toxicon.2013.05.004","article-title":"The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis","volume":"71","author":"RS Broide","year":"2013","journal-title":"Toxicon"},{"issue":"1","key":"pbio.3000618.ref078","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/BJ20131668","article-title":"Multiple conformations of a single SNAREpin between two nanodisc membranes reveal diverse pre-fusion states","volume":"459","author":"J Shin","year":"2014","journal-title":"The Biochemical journal"},{"issue":"14","key":"pbio.3000618.ref079","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1042\/BCJ20160339","article-title":"Complexin splits the membrane-proximal region of a single SNAREpin","volume":"473","author":"L Yin","year":"2016","journal-title":"The Biochemical journal"},{"key":"pbio.3000618.ref080","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1107\/S1399004714017039","article-title":"New methods for indexing multi-lattice diffraction data","volume":"70","author":"RJ Gildea","year":"2014","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"pbio.3000618.ref081","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1107\/S0907444905036693","article-title":"Scaling and assessment of data quality","volume":"62","author":"P Evans","year":"2006","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"pbio.3000618.ref082","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"The CCP4 suite: programs for protein crystallography","volume":"50","author":"Collaborative Computational Project, Number 4","year":"1994","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"pbio.3000618.ref083","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"AJ McCoy","year":"2007","journal-title":"J Appl Crystallogr"},{"key":"pbio.3000618.ref084","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"GN Murshudov","year":"2001","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"pbio.3000618.ref085","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"P Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"7","key":"pbio.3000618.ref086","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/nprot.2008.91","article-title":"Automated macromolecular model building for X-ray crystallography using ARP\/wARP version 7","volume":"3","author":"G Langer","year":"2008","journal-title":"Nat Protoc"},{"key":"pbio.3000618.ref087","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"VB Chen","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"}],"container-title":["PLOS Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.3000618","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T19:09:14Z","timestamp":1614884954000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.3000618"}},"subtitle":[],"editor":[{"given":"Michel R.","family":"Popoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":87,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pbio.3000618","relation":{},"ISSN":["1545-7885"],"issn-type":[{"value":"1545-7885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]}}}